Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis

Yu Fukuda(Pharmaceutical Biotechnology (Czechia)), John D. Schuetz(St. Jude Children's Research Hospital)
JCI Insight
August 2, 2017
Cited by 54


Related Papers